Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders (Q43297018)

18 November 2017

title

Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders (English)

1 reference

18 November 2017

Daisuke Watanabe

1

1 reference

18 November 2017

Akiyo Tanabe

2

1 reference

18 November 2017

Mitsuhide Naruse

3

1 reference

18 November 2017

Shunichi Morikawa

4

1 reference

18 November 2017

Taichi Ezaki

5

1 reference

18 November 2017

Kazue Takano

6

1 reference

18 November 2017

publication date

7 August 2009

1 reference

18 November 2017

published in

Hypertension Research

1 reference

18 November 2017

volume

32

1 reference

18 November 2017

issue

9

1 reference

18 November 2017

page(s)

807-815

1 reference

The metabolic syndrome and chronic kidney disease in U.S. adults

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

An association between body mass index and estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renal injury in the extremely obese patients with normal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

How does proteinuria cause progressive renal damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renin-angiotensin-aldosterone system and progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

Obesity, proteinuria and progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Glomerular hemodynamics in severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Glomerular sclerosis in patients with massive obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Obesity and target organ damage: the kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Myofibroblast phenotypes expression in experimental renal scarring

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Renal injury from angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.106

7 January 2021

Identifiers

DOI

10.1038/HR.2009.106

1 reference

18 November 2017

1 reference